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Introduction: Although a full understanding of the role of sleep is debated, it is 
widely accepted that sleep is important for recovery from heavy exercise. Recent research 
suggests that sleep restriction (SR) may negatively impact recovery and subsequent 
performance. It is unknown if caffeine supplementation mitigates this performance 
decrement. Our objective was to investigate the effect of caffeine supplementation on 
exercise performance following one night of SR in trained cyclists. 
Methods: Subjects (n=10) completed a 3-km time trial (TT) and an exhaustive bout 
of exercise in the evening (EX1), then returned to repeat the TT the following morning 
(EX2). Exercise trials were separated by a full night of sleep (FULL) or a night of restricted 
sleep (SR). Perceived fatigue was also assessed prior to EX2. Caffeine (CAF) or placebo 
(PLA) treatments were given before the start of EX2. A randomly counterbalanced, double 
blind, placebo controlled design was used to compare the effects of four different treatment 
conditions: FULL/PLA, SR/PLA, FULL/CAF, SR/CAF.  
Results: Data were analyzed using magnitude-based inferences to compare 
differences in EX2 performances only. Power output was ‘possibly’ greater (0.9 ± 3.6%) 
following SR/PLA compared to FULL/PLA. Power output was ‘likely’ higher (5.5 ± 4.8%) 
following SR/CAF compared with SR/PLA. Perceived fatigue was rank ordered as 1) 
SR/PLA, 2) SR/CAF, 3) FULL/PLA, 4) FULL/CAF. Specifically, CAF ‘very likely’ 
reduced perceived fatigue following SR compared to SR PLA, but remained ‘likely’ higher 





Conclusion: These data show that caffeine has the ability to mitigate performance 
decrements resulting from a single night of SR following heavy exercise. Caffeine also 
prevented increases in perceived fatigue following SR.  
 








Though a full understanding of the importance of sleep has yet to be clearly 
explained, sleep is required for optimal physiological function. Therefore, it is widely 
recommended that adults sleep 7 to 9 hours a night. However, much of the population falls 
short of these guidelines (18, 60). The most recent poll conducted by the National Sleep 
Foundation found that 40% of respondents acquired less than 6.9 hours of sleep on 
weekdays (1).  Sleep loss can occur through sleep deprivation or sleep restriction. Sleep 
deprivation is the complete absence of sleep, while sleep restriction is interrupted sleep 
cycles; these interruptions can occur through delayed sleep, intermittent waking, or early 
awakening.  The importance of sleep is believed to be related to a number of different 
factors. A commonly accepted theory revolves around energy conservation, as sleep 
reduces daily metabolic requirements and energy expenditure (15, 45). Also, despite early 
data to the contrary, recent work clearly indicates that cognitive function is compromised 
following sleep loss, suggesting the central nervous system is reliant on sleep for optimal 
functioning (20, 59, 62).  Finally, there is compelling evidence that long-lasting 
immunological memory is built through short adaptive immune responses that occur during 
sleep (7). When adequate sleep is not achieved, the integrity of these systems is 
compromised.  
Athletes in particular require sufficient sleep, so as to facilitate recovery from the 
physiological and psychological demands of heavy training and competition (3, 14, 35). 





restoring the metabolic cost of the wakeful state, and enhancing memory, learning, and 
synaptic plasticity (19, 25). Furthermore, when sleep is curtailed during periods of heavy 
training, recovery is adversely affected and the potential for overtraining and maladaptation 
arises, suggesting the necessity of sleep as a mode of recovery for athletes (4). When sleep 
loss occurs acutely, restoration of neurocognition and the immune system is inhibited, and 
could be a factor leading to decreased performance (25). Thus, sleep loss in athletes has 
the potential to negatively affect the adaptive physiological and psychological recovery 
processes. Moreover, athletes are especially susceptible to sleep loss. Many athletes 
routinely perform consecutive days of high-intensity training bouts, and heavy training has 
been shown to lead to impaired sleep (28). Further, the psychological stress of multi-day 
competitions or target competitions can also lead to insufficient sleep. A survey examining 
sleep habits of 632 athletes before an important competition or game reported that 62.3% 
of them had experienced poor sleep in the nights before a sports event at least once in the 
previous twelve months. Some athletes reported lost sleep had no effect on their athletic 
performance, while others reported decrements in mood, alertness, and athletic 
performance (17). When their schedules interfere with their sleep, whether involving late 
bedtime or early arousal, the potential for short- and long-term consequences arises. The 
deleterious effects of sleep on recovery and physical performance are therefore of interest 
to both coaches and athletes. 
Predictably, complete sleep deprivation has a negative impact on athletic 
performance varying from strength and anaerobic exercise to prolonged aerobic exercise 
(10, 38, 39, 43, 50, 52, 55). This could be at least partially related to the well documented 





Interestingly, the effects of sleep deprivation on physical performance are conflicting. With 
the exception of one study, it would seem that sleep deprivation ranging from 30 to 60 
hours decreases muscular strength and endurance (57). Significant decreases in muscular 
strength and endurance were seen through decreased vertical jump, isokinetic knee 
extension and flexion peak torque, and peak isometric voluntary force (10, 52, 58). 
Conversely, data indicate that short-duration performances seem to be unaffected by sleep 
deprivation (50, 55, 57, 58), with the exception of a recent report that 15-m sprint time was 
significantly increased when subjects incurred 30 hours of sleep deprivation compared to 
a full night of sleep (52). While the literature currently agrees that sleep deprivation can 
substantially impair aerobic performance (3-20%), the mechanisms for these decrements 
arise have yet to be explained. It would seem that cardiovascular, metabolic and ventilatory 
changes occur as a result of sleep deprivation; however the effects of sleep on these 
parameters are equivocal. In certain conditions, heart rate, oxygen consumption, and 
ventilatory responses to exercise change with sleep deprivation, while in others these 
measures stay the same. (38, 39, 43, 50, 57). Discrepancies in protocol may lead to the 
conflicting evidence; especially in regards to hours of sleep deprivation and exercise 
conditions. Studies have examined the effects of sleep deprivation in various amounts 
exceeding 24 hours on performance outcomes which could include time to exhaustion, total 
work, total distance covered, and maximal exercise intensity (5, 29, 37, 38, 42, 43). So, it 
appears that sleep deprivation can lead to decreased athletic performance, most notably in 
prolonged exercise. 
In addition to sleep deprivation, some data has been gathered on the effects of acute 





have equivocal effects on muscular strength. Reilly and Piercy reported that various 
submaximal and maximal weight lifting tasks were negatively affected by sleep restriction,  
while others report that handgrip and maximal voluntary contraction of muscles may either 
decrease or remain unchanged, respectively (24, 48, 49, 54). The effect of sleep restriction 
on anaerobic performance remains equivocal. While two studies have shown that there is 
no change in anaerobic performance the morning following sleep restriction, a few have 
reported decreased mean and peak power in a Wingate test the morning or evening 
following sleep restriction (2, 24, 41, 55). Interestingly, all of the studies that demonstrated 
performance decrements utilized early awakening as their form of sleep restriction (2, 24, 
56). Similarly to total deprivation, the decrements seen in performance following sleep 
restriction could be due to effects on RPE and mood states as opposed to physiological 
mechanisms (24, 42, 56). Less is known about the effects of sleep restriction on aerobic 
performances. While two studies showed sleep restriction did not affect incremental 
running and cycling test durations the next day, others have demonstrated that sleep 
restriction decreases performance in intermittent recovery and incremental cycling tests 
(40, 42, 44, 48).  Despite conflicting reports, it is clear that sleep restriction in the form of 
early awakening is more disturbing to afternoon performance than delayed-bedtime 
restriction for both aerobic and anaerobic exercise (2, 40, 56). It is important to consider 
that the consequences of sleep restriction might vary due to individual differences such as 
gender, age, morningness-eveningness classification (e.g. chronotype), amount of sleep 
required, and sleep latency differences (9, 12, 26, 27). In light of the current literature, it 






Virtually everything that is known about sleep restriction and exercise performance 
has been derived from subjects that refrained from heavy exercise leading up to the night 
of sleep restriction. It is logical to expect that sleep loss following demanding exercise may 
have a more pronounced effect on next-day exercise.  In support of this idea, our laboratory 
recently found that one night of sleep restriction following heavy exercise impairs short-
duration cycling performance the following day by approximately 4 percent (13). Because 
sleep disruption is inevitable and markedly detrimental to performance, it is worthwhile to 
examine potential strategies to attenuate performance losses. One possible strategy to 
minimize the effects of sleep restriction on performance is caffeine supplementation; as 
caffeine would seem to have the potential to mitigate the detrimental effects of sleep 
restriction through increased neurocognitive function and decreased perceived exertion (8). 
Extensive research has demonstrated the effectiveness of caffeine as an ergogenic aid for 
aerobic and anaerobic performance (22, 33, 34, 61). Additionally, our laboratory recently 
reported that caffeine can enhance 3-km cycling time trial performance, especially early in 
the day (8, 46). The extent to which caffeine may be able to compensate for the negative 
effects of sleep loss has not been examined. Considering the efficacy of caffeine as a CNS 
stimulant, it is plausible that caffeine could attenuate some of neurocognitive factors that 
might lead to performance impairments (16). Therefore, the purpose of this investigation 
is to test the hypothesis that caffeine supplementation will attenuate but not eliminate the 









Aims and Hypotheses 
Aim 1: To determine if caffeine supplementation attenuates the negative effects of sleep 
restriction on 3-km cycling TT performance. 
Hypothesis 1: Caffeine supplementation will attenuate but not completely offset the 
negative effects of sleep restriction on 3-km cycling TT performance.   
Aim 2: To determine if caffeine supplementation attenuates the negative effects of sleep 
restriction on muscle work during 30 isokinetic leg extension repetitions. 
Hypothesis 2: Caffeine supplementation will attenuate but not completely offset the 
negative effects of sleep restriction on muscle work during 30 isokinetic leg extension 
repetitions. 
Aim 3: To determine if caffeine supplementation attenuates the negative effects of sleep 
restriction on mood states. 
Hypothesis 3: Caffeine supplementation will attenuate but not completely offset the 







 Sleep plays an important role in psychological and physiological recovery from 
exercise. Despite a resounding belief from athletes and coaches that sleep is critical to 
recovery and performance, the role sleep plays in enhancing recovery and promoting 
performance is still ambiguous. Little has been done to determine the effects of sleep 
restriction on recovery from heavy exercise and subsequent performance. Sleep restriction 
appears to negatively affect performance in athletes, especially when sleep restriction 
occurs in the form of early awakening. This seems to be due to negative impacts on 
cognitive functioning and mood states, however there may be underlying physiological 
mechanisms as well. Furthermore, potential strategies to mitigate performance decrements 
observed following sleep restriction have yet to be tested. Considering the prevalence of 
sleep loss in athletic populations, it is important to investigate the effects sleep restriction 
has on recovery from exercise as well as potential ways to ameliorate resulting decrements. 
The current study has the potential to determine if caffeine supplementation can serve as a 












Eight to fifteen male and female recreational cyclists from James Madison 
University will participate in this study. All subjects must perform a minimum of 30 
minutes of cycling, one to two days per week, for at least three months prior to the study, 
and possess a maximum oxygen consumption (VO2max) of ≥ 40 ml/min/kg to qualify for 
participation. Additionally, participants will score ≤ 7 on the Pittsburg Sleep Quality Index 
(PSQI) to ensure they have “normal” sleeping habits (11). Participants will be informed of 
the experimental protocol, risks, and benefits before providing written consent. The study 
will has been approved by the James Madison Institutional Review Board. 
 
Preliminary Testing 
           Following height and weight measurements, participants will perform an 
incremental exercise test to exhaustion on a cycle ergometer (Velotron, Racermate, Inc., 
Seattle, WA, USA) to determine VO2max and maximum power in watts (Wmax). The 
participants will warm up for five minutes at a self-selected workload, then begin the test 
at a workload between 100 and 175 W. The workload will increase every 2 minutes in 50 
W increments until volitional fatigue or inability to maintain a cadence of 50 RPM or 
higher for more than 10 seconds. Expired air will be collected throughout the test and 
oxygen consumption (VO2) will be assessed using the Moxus Modular Metabolic System 







           Participants will complete a familiarization phase followed by four experimental 
phases, each separated by five to seven days. The familiarization and experimental phases 
will consist of two exercise sessions performed on consecutive days (EX1 and EX2). EX1 
will consist of baseline performance testing followed by an exercise protocol designed to 
elicit fatigue. EX2 will be performed the following morning to assess recovery from the 
exercise protocol, and will only include the performance testing. EX1 and EX2 during the 
experimental phases will be separated by a night of full sleep (FULL) or a night of restricted 
sleep (SR). Sleep will be assigned to each participant in a randomized, crossover design. 
Participants will be informed of their designated sleep condition following the exercise 
protocol on EX1 and not before, to prevent reactive behavior changes leading up to the 
experimental trials.  
 
Familiarization Phase 
The familiarization phase will consist of EX1 and EX2 trials (as described below) 
without controls for sleep, diet, and physical activity. The participants will complete the 
trials at predetermined intensities to confirm they can complete the protocol, familiarize 
themselves with the equipment, and reduce learning-related improvements in performance 
during the experimental trials.  
 
Experimental Trial 1 (EX1) 
 Participants will arrive at the Human Performance Lab between 3:00 and 5:00pm, 





arrive fasted for ≥2 hours. Upon arrival, participants will be equipped with a heart rate 
(HR) monitor (Polar; Lake Success, NY, USA) to wear, and then rest in a reclined position 
for five minutes. At the cessation of the five minute period, resting HR will be recorded. 
Participants will then warm up for 20 minutes (10 minutes at 50% Wmax followed by 10 
minutes at 60% Wmax) on the aforementioned cycle ergometer, during which metabolic 
measurements will be assessed, as described below. Following the 20 minute warm-up, 
participants will begin a computer simulated 3-km cycling time trial. Participants will be 
encouraged to give a maximal effort before the time trial. Following the time trial, 
participants will cool down on the bicycle ergometer at a self-selected intensity between 
50-100W for 10 minutes. The cool-down intensity will be matched in subsequent trials. 
Following the cool-down, participants will perform three warm-up and 30 maximal single-
leg extensions at 120°/second on an isokinetic dynamometer (Biodex Multi-Joint System - 
PRO, Biodex Medical Systems, Inc., Shirley, NY, USA). Upon completion of leg 
extensions, participants will perform a 60-minute sprint interval session, previously used 
in our laboratory (13). Intervals will alternate between 2 minutes at 95% Wmax and 2 
minutes at 50% Wmax. If participants cannot maintain a cadence of ≥50 rpm at 95% 
Wmax, power output will be reduced by 10% for following sprints.  
 
Experimental Trial 2 (EX2) 
 
Participants will begin EX2 between 7:00am and 9:00am the following morning. 
Participants will eat a standardized breakfast (detailed below) 2 hours prior to EX2. 





recorded after 5 minutes of rest at the start of EX2. Following rest, participants will 
complete an assessment of transient mood states (POMS-2, Multi-Health System; North 
Tonawanda, NY, USA). Participants will then repeat the warm up and time trial protocol 
from EX1 and cool down on the cycle ergometer at their previously selected intensity. 




 Participants will undergo the four experimental trials with 5-7 days between the 
end of one trial and beginning of another. Participants will be instructed to initiate sleep 
between 10:00 pm and 12:00 am for all FULL and SR trials, replicating the same onset 
time in all experimental phases. For FULL, participants will be instructed to set their wake-
up time for 8 hours following sleep onset. After waking up, participants will report to the 
laboratory for EX2. For SR, participants will be instructed to set their wake-up time 3.5 
hours following sleep onset. After waking up, participants will immediately report to the 
laboratory whereupon an investigator will accompany them to ensure wakefulness until 
testing begins. The start time of EX2 will remain constant throughout the experimental 
phases. The Sleep Cycle smartphone application (Northcube, AB, Göteborg, Sweden) will 
be used to evaluate the two nights preceding EX1 and the night before EX2. Participants 
will place the smart phone on their mattress in accordance with manufacturer 
recommendations and sleep data will be estimated based on motion detection. In addition 
to Sleep Cycle, sleep data will be acquired through the use of an Actigraph Accelerometer 





Caffeine/Placebo Capsules:  
 A randomly counterbalanced, double blind, placebo controlled design will be 
utilized to compare the effects of four different treatment conditions. Participants will 
receive 6mg/kg body weight in capsule form containing either rice flour (PLA) or 
anhydrous caffeine. Capsules will be ingested 1 hour before each EX2 trial. The four 
treatment conditions will be: FULL with caffeine capsule (FULL/CAF), 2. FULL with 
placebo capsule (FULL/PLA), 3. SR with caffeine capsule (SR/CAF), and 4. SR with 
placebo capsule (SR/PLA). 
 
Dependent Measures 
3-km Time Trial Performance 
3-km time trial performances will be performed on the Velotron cycle ergometer in 
all EX trials. Time to completion and average power output will be used as the primary 
performance measures.  
 
Blood Lactate and Glucose 
Blood lactate and glucose will be taken at minute 18 of the 20 minute warm-up 
preceding the 3-km time trial in all EX trials. A finger-stick blood draw will be performed 
and blood will be analyzed in a YSI 2300 Stat Plus Analyzer (YSI Incorporated; Yellow 








Muscle Function  
Total work and fatigue index will be determined using the Biodex dynamometer 
mentioned above at 120°/second during all EX trials.  
 
Oxygen Consumption, Ventilation, & Respiratory Exchange Ratio (VO2, VE, & RER) 
VO2, VE, and RER will be measured using a Moxus metabolic cart during the last 
5 minutes of the 20 minute warm-up preceding the 3-km time trial in all EX trials. Values 
obtained in minutes 17-20 will be averaged and recorded. 
 
Heart Rate & Rate of Perceived Exertion (HR & RPE) 
During all EX trials, HR and RPE will be obtained at minute 20 of the 20 minute 
warm-up preceding the 3-km time trial.  
 
Dietary and Exercise Controls 
 Participants will record all food and beverage intake for 24 hours before EX1 and 
continue recording until sleep onset that night. After the first EX phase, copies of food and 
beverage logs will be provided to the participants to replicate diet habits for the remaining 
phases. Participants will begin all EX trials after a ≥2 hour fast. Within one hour of 
completing EX1, participants will consume a meal replacement protein shake (Ensure 
Original Nutrition Shake, Abbott Laboratories). Participants will also be asked to abstain 
from consuming any other macronutrients within two hours of ending EX1. For all 
conditions, participants will be instructed to consume a standardized breakfast 2 hours 





yogurt equaling approximately 400 calories. Participants will also be instructed to record 
all physical activity for 72 hours prior to EX1 in all phases, and keep physical activity 
habits for all phases. Additionally, they will be instructed to avoid physical activity the day 
of EX1 and between EX1 and EX2.  
 
Statistics 
Total time to completion and mean power output (Watts) during the 3-km time trial 
will be used as the performance measures. Data will be log transformed to reduce the 
effects of non-uniformity. Magnitude-based inferences will be derived about the data using 
methods previously described by Hopkins and colleagues (32). A previously determined 
“smallest worthwhile change” in performance will be used as a threshold value for a 
condition effect (EX1 time trial vs. EX2 time trial). The smallest worthwhile change in 
performance is defined as 0.3 x the within subject variability of select groups of elite 
cyclists across repeated time trials (CV = 1.5% for time and estimated 4.5% for power) 
(31). For all other variables that will be analyzed, the threshold value for a substantial 
treatment effect will be defined as 0.2 x within-subject standard deviation, under resting 
conditions.  
Publically available spreadsheets will be used to the likelihood of the true treatment 
effect (of the population) reaching the substantial change threshold (30). The percent 
likelihoods will be classified as: <1% almost certainly no chance, 1-5% = very unlikely, 5-
25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = very likely, >99% almost 
certain. Clinical inference criteria will be used to classify the effects of all conditions on 





is <25% and the effect is clear, it will be classified as ‘trivial’. If the percent chance of the 
effect reaching the substantial change threshold for benefit exceeds 25%, but the chance 
for harm is >0.5%, the effect will be considered “unclear”. An exception to the 0.5% chance 
of harm criterion will be made if the benefit/harm odds ratio is >66, in which the case of 
the effect will be interpreted as “clear”.  
Following individual condition analysis, treatment comparisons (FULL/CAF vs 
FULL/PLA vs SR/CAF vs SR/PLA) outcomes will be assessed using the previously 
mentioned spreadsheets (30). The classification system described above will apply, but 
mechanistic criteria will be used. If 90% confidence intervals include values that exceed 
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Introduction: Although a full understanding of the role of sleep is debated, it is 
widely accepted that sleep is important for recovery from heavy exercise. Recent research 
suggests that sleep restriction (SR) may negatively impact recovery and subsequent 
performance. It is unknown if caffeine supplementation mitigates this performance 
decrement. Our objective was to investigate the effect of caffeine supplementation on 
exercise performance following one night of SR in trained cyclists. 
Methods: Subjects (n=10) completed a 3-km time trial (TT) and an exhaustive bout 
of exercise in the evening (EX1), then returned to repeat the TT the following morning 
(EX2). Exercise trials were separated by a full night of sleep (FULL) or a night of restricted 
sleep (SR). Perceived fatigue was also assessed prior to EX2. Caffeine (CAF) or placebo 
(PLA) treatments were given before the start of EX2. A randomly counterbalanced, double 
blind, placebo controlled design was used to compare the effects of four different treatment 
conditions: FULL/PLA, SR/PLA, FULL/CAF, and SR/CAF.  
Results: Data were analyzed using magnitude-based inferences to compare 
differences in EX2 performances only. Power output was ‘possibly’ greater (0.9 ± 3.6%) 
following SR/PLA compared to FULL/PLA. Power output was ‘likely’ higher (5.5 ± 4.8%) 
following SR/CAF compared with SR/PLA. Perceived fatigue was rank ordered as 1) 
SR/PLA, 2) SR/CAF, 3) FULL/PLA, 4) FULL/CAF. Specifically, CAF ‘very likely’ 
reduced perceived fatigue following SR compared to SR PLA, but remained ‘likely’ higher 





Conclusion: These data show that caffeine has the ability to mitigate performance 
decrements resulting from a single night of SR following heavy exercise. Caffeine also 








A full understanding of the precise physiological role of sleep has yet to be fully 
elucidated, but it is clear that sleep is required for optimal function. It is widely 
recommended that adults sleep 7 to 9 hours a night. Despite this recommendation, much 
of the population falls short of these guidelines (18, 60). The importance of sleep is 
believed to be related to energy conservation and optimal central nervous and immune 
system function (7, 15, 20, 45, 59, 62). Proper sleep may be critical to recovery for 
athletes due to maintenance of the immune system, restoring the metabolic cost of the 
wakeful state, preventing overtraining, and enhancing memory, learning, and synaptic 
plasticity (4, 19, 25). In addition, athletes are particularly susceptible to sleep loss due to 
heavy training and psychological stress of competitions (17, 28). Therefore, it is 
advantageous for both coaches and athletes to understand the effects of sleep on recovery 
and physical performance. 
 Complete sleep deprivation (SDEP; i.e. >24 hrs sleep loss) reportedly has 
negative impacts on athletic endeavors, ranging in duration from short sprints and 
Wingate tests (90s) to endurance trials lasting approximately 35 to 100 minutes. 
However, there is still some debate regarding the mechanisms which underlie these 
performance decrements (38, 43, 52, 55, 57). The detrimental effects of SDEP on 
performance have been at least partially attributed to changes in perceived exertion and 
mood states following SDEP, but the direct mechanisms have yet to be fully determined 
(38, 43, 51, 52). Although athletes may occasionally experience SDEP, it is presumably 
more common for athletes to experience acute sleep restriction (SR; abbreviated sleep 





seem that SR can negatively impact peak and mean muscular power, especially when 
performance is in the afternoon (2, 24, 41, 55). The effects of SR on longer performances 
such as cycling and running time to exhaustion as well as shuttle running are 
unequivocal. Early research indicated that SR had no effect on these performances. 
However, more recent data suggest that SR in the form of early awakening as opposed to 
delayed bedtime can inhibit performance in the afternoon suggesting the type of SR as 
well as the time of performance are key factors when investigating the implications of SR 
(40, 42, 44, 48).  
 Prior studies on SR and exercise performance had subjects refrain from heavy 
exercise leading up to the night of SR. Our laboratory recently found that one night of SR 
following heavy exercise impairs short-duration cycling performance by approximately 
4% (13). Because SR is inevitable and in some cases, detrimental to performance, it is 
worthwhile to examine potential strategies to attenuate performance detriments following 
SR. One potential strategy is caffeine supplementation. Extensive research has 
demonstrated the effectiveness of caffeine as an ergogenic aid for performance through 
increased neurocognitive function and decreased perceived exertion (22, 33, 34, 61). 
Specifically, Souissi et al recently investigated the effects of caffeine on physical and 
cognitive performance following 36 hours of SDEP. Caffeine ingestion following SDEP 
improved mood states, cognitive function, squat jump and Wingate performance (53). 
While this data presents a strong case for caffeine mitigating the performance losses seen 
following SDEP, it is important to note that the tests were performed in the afternoon, 
sleep loss occurred through total SDEP, and subjects were fully rested leading into the 





detrimental performance following sleep restriction. Therefore, the purpose of the present 
investigation is to test the hypothesis that caffeine supplementation will attenuate but not 








Ten male (n=8) and female (n=2) recreational cyclists from James Madison 
University participated in this study. All subjects performed a minimum of 30 minutes of 
cycling, one to two days per week, for at least three months prior to the study, and possessed 
a maximum oxygen consumption (VO2max) of ≥ 40 ml/min/kg. Demographic information 
of the participants is highlighted in Table 1. Additionally, participants scored ≤ 7 on the 
Pittsburg Sleep Quality Index (PSQI) to ensure they had “normal” sleeping habits (11). 
Participants were informed of the experimental protocol, risks, and benefits before 
providing written consent. The study was approved by the James Madison Institutional 
Review Board 
Preliminary Testing 
           Following height and weight measurements, participants performed an incremental 
exercise test to exhaustion on a cycle ergometer (Velotron, Racermate, Inc., Seattle, WA, 
USA) to determine VO2max and maximum power in watts (Wmax). The participants 
warmed up for five minutes at a self-selected workload, then began the test at a workload 
between 100 and 175 W based on self-reported training workloads. The workload increased 
every 2 minutes in 50 W increments until volitional fatigue or inability to maintain a 
cadence of 50 RPM or higher for more than 10 seconds. Breath samples were collected 
throughout the test and oxygen consumption was assessed using the Moxus Modular 
Metabolic System (AEI Technologies, Pittsburgh, PA, USA). VO2max was be determined 






           Participants completed a familiarization phase followed by four experimental 
phases, each separated by five to seven days. The familiarization and experimental phases 
consisted of two exercise sessions performed on consecutive days (EX1 and EX2). EX1 
consisted of baseline performance testing followed by an exercise protocol designed to 
elicit fatigue. EX2 was performed the following morning to assess recovery from the 
exercise protocol, and only included the performance testing. EX1 and EX2 during the 
experimental phases were separated by a night of full sleep (FULL) or a night of restricted 
sleep (SR). Sleep condition was assigned to each participant in a randomized, crossover 
design. Participants were informed of their designated sleep condition following the 
exercise protocol on EX1 and not before, to prevent reactive behavior changes leading up 
to the experimental trials. A schematic of the experimental design can be found in Figure 
1.  
Familiarization Phase 
The familiarization phase consisted of EX1 and EX2 trials (as described below), 
however sleep, diet, and physical activity were not controlled. These trials were performed 
at predetermined intensities calculated from Wmax to confirm they could complete the 
protocol, familiarize themselves with the equipment, and reduce learning-related 
improvements in performance during the experimental trials. Appropriate intensities for 
the various components of the experimental trials are defined below. 
Experimental Trial 1 (EX1) 
 Participants arrived at the Human Performance Lab between 3:00 and 5:00pm, 





having fasted from food for ≥2 hours. Upon arrival, participants were equipped with a heart 
rate (HR) monitor (Polar; Lake Success, NY, USA) to wear, and then rested in a reclined 
position for five minutes. At the cessation of the five minute period, resting HR was 
recorded and weight was measured. Participants warmed up for 20 minutes (10 minutes at 
50% Wmax followed by 10 minutes at 60% Wmax) on the aforementioned cycle 
ergometer, during which metabolic measurements were assessed, as described below. 
Following the 20 minute warm-up, participants began a computer simulated 3-km cycling 
time trial. Participants were encouraged to give a maximal effort before the time trial. 
Following the time trial, participants cooled down on the bicycle ergometer at a self-
selected intensity between 50-100W for 10 minutes. The cool-down intensity was matched 
in subsequent trials. Following the cool-down, participants performed three warm-up and 
30 maximal single-leg extensions at 120°/second on an isokinetic dynamometer (Biodex 
Multi-Joint System - PRO, Biodex Medical Systems, Inc., Shirley, NY, USA). Upon 
completion of leg extensions, participants performed a 60-minute sprint interval session, 
previously used in our laboratory (13). Intervals alternated between 2 minutes at 95% 
Wmax and 2 minutes at 50% Wmax. If participants could not maintain a cadence of ≥50 
rpm at 95% Wmax, power output was reduced by 10% for following sprints. Upon leaving 
the laboratory, participants were instructed to continue refraining from the consumption of 
alcohol, tobacco, or caffeine.  
Experimental Trial 2 (EX2) 
Participants began EX2 between 7:00am and 9:00am the following morning. 
Participants ate a standardized breakfast (detailed below) 2 hours prior to EX2. 





after 5 minutes of rest at the start of EX2. Following rest, participants completed an 
assessment of transient mood states (POMS-2, Multi-Health System; North Tonawanda, 
NY, USA). Participants then repeated the warm up and time trial protocol from EX1. 
Participants cooled down on the cycle ergometer at their previously selected intensity. 
Following the cool-down, participants performed the same leg-extension protocol from 
EX1.  
Sleep Protocol 
 Participants were instructed to initiate sleep between 10:00 pm and 12:00 am for 
all FULL and SR trials, and replicated the same onset time in all experimental phases. For 
FULL, participants were instructed to set their wake-up time for 8 hours following sleep 
onset. After waking up, participants reported to the laboratory for EX2. For SR, participants 
were instructed to set their wake-up time 3.5 hours following sleep onset. After waking up, 
participants immediately reported to the laboratory whereupon an investigator 
accompanied them to ensure wakefulness until testing began. The start time of EX2 
remained constant throughout the experimental phases. The Sleep Cycle smartphone 
application (Northcube, AB, Göteborg, Sweden) was used as to confirm adherence for the 
two nights preceding EX1 and the night before EX2. Participants placed the smart phone 
on their mattress in accordance with manufacturer recommendations and sleep data was 
estimated based on motion detection. In addition to Sleep Cycle, sleep data was acquired 
through the use of an accelerometer (ActiGraph GT3X+, ActiGraph Corp, Pensacola, FL, 
USA) worn on the non-dominant wrist. Sleep amounts acquired by participants can be 






Caffeine/Placebo Capsules:  
 A randomly counterbalanced, double blind, placebo controlled design was utilized 
to compare the effects of four different treatment conditions. No treatments were 
administered during the familiarization trials. During the experimental trials participants 
were given 6mg/kg body weight in capsule form containing either rice flour (PLA) or 
anhydrous caffeine (CAF). Capsules were ingested 1 hour before each EX2 trial. The four 
treatment conditions were: FULL with caffeine capsule (FULL/CAF), 2. FULL with 
placebo capsule (FULL/PLA), 3. SR with caffeine capsule (SR/CAF), and 4. SR with 
placebo capsule (SR/PLA). 
Dependent Measures 
3-km Time Trial Performance 
3-km time trial performances were performed on the Velotron cycle ergometer in 
all EX trials. Time to completion and average power output were used as the primary 
performance measures.  
Responses to Fixed-Load Exercise 
Oxygen Consumption, Ventilation, & Respiratory Exchange Ratio (VO2, VE, and 
RER) 
VO2, VE, and RER were measured using a Moxus metabolic cart during the last 5 
minutes of the 20 minute fixed-load phase preceding the 3-km time trial in all 
experimental trials. Values obtained in minutes 17-20 were averaged and recorded. 
Heart Rate & Rate of Perceived Exertion (HR & RPE) 
During all experimental trials, HR and RPE were obtained at minute 20 of the 20 






Muscle Function  
Total work, peak torque, and fatigue index over 30 maximal leg extensions were 
determined using the Biodex dynamometer mentioned above at 120°/second during all EX 
trials. Total work was the sum of work done in Joules (J) over the course of the 30 maximal 
leg extensions. Fatigue index was calculated for the 30 maximal leg extensions as a percent 
change using the formula 
[
𝑃𝑒𝑎𝑘 𝑇𝑜𝑟𝑞𝑢𝑒 5 𝑠𝑡𝑟𝑜𝑛𝑔𝑒𝑠𝑡 𝑟𝑒𝑝𝑖𝑡𝑖𝑡𝑖𝑜𝑛𝑠 − 𝑃𝑒𝑎𝑘 𝑇𝑜𝑟𝑞𝑢𝑒 5 𝑤𝑒𝑎𝑘𝑒𝑠𝑡 𝑟𝑒𝑝𝑒𝑡𝑖𝑡𝑖𝑜𝑛𝑠 
𝑃𝑒𝑎𝑘 𝑇𝑜𝑟𝑞𝑢𝑒 5 𝑠𝑡𝑟𝑜𝑛𝑔𝑒𝑠𝑡 𝑟𝑒𝑝𝑖𝑡𝑖𝑡𝑖𝑜𝑛𝑠
] × 100 
Dietary and Exercise Controls 
 Participants recorded all food and beverage intake for 24 hours before EX1 and 
continued recording until sleep onset that night. After the first EX phase, copies of food 
and beverage logs were provided to the participants to replicate diet habits for the 
remaining phases. Participants began all EX trials after a ≥2 hour fast. Within one hour of 
completing EX1, participants consumed a meal replacement protein shake. Participants 
were asked to abstain from consuming any other macronutrients within two hours of ending 
EX1. For all conditions, participants were instructed to consume a standardized breakfast 
2 hours before beginning EX2. The standardized breakfast consisted of orange juice, cereal, 
and yogurt equaling approximately 400 calories. Participants were also instructed to record 
all physical activity for 72 hours prior to EX1 in all phases, and keep physical activity 
habits for all phases. Additionally, they were instructed to avoid physical activity the day 







Total time to completion (min) and mean power output (Watts) were used as the 
main performance measures, while isokinetic testing was used to assess muscle function. 
Data was log transformed to reduce the effects of non-uniformity. Magnitude-based 
inferences were derived about the data using methods previously described by Hopkins 
and colleagues (32). A previously determined “smallest worthwhile change” in 
performance was used as a threshold value for a between condition effect (EX2 time trial 
vs. EX2 time trial). The smallest worthwhile change in performance was defined as 0.3 x 
the within subject variability of select groups of elite cyclists across repeated time trials 
(CV = 1.5% for time and estimated 4.5% for power) (31). For all other variables that were 
analyzed, the threshold value for a substantial treatment effect was defined as 0.2 x within-
subject standard deviation, under resting conditions.  
Publically available spreadsheets were used to the likelihood of the true treatment 
effect (of the population) reaching the substantial change threshold (30). The percent 
likelihoods were classified as: <1% almost certainly no chance, 1-5% = very unlikely, 5-
25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = very likely, >99% almost 
certain. Clinical inference criteria were used to classify the effects of all conditions on 
performance. If the percent chance of the effect reaching the substantial change threshold 
was <25% and the effect is clear, it was classified as ‘trivial’. If the percent chance of the 
effect reaching the substantial change threshold for benefit exceeded 25%, but the chance 
for harm was >0.5%, the effect was considered “unclear”. An exception to the 0.5% chance 
of harm criterion was made if the benefit/harm odds ratio was >66, in which the case of the 





Following individual condition analysis, treatment comparisons (FULL/CAF vs 
FULL/PLA vs SR/CAF vs SR/PLA) outcomes were assessed using the previously 
mentioned spreadsheets (30). The classification system described above was applied, but 
mechanistic criteria was used. If 90% confidence intervals included values that exceeded 
the substantial change threshold for both a positive and negative effect, the effect was 









3-km Time Trial Performance 
Statistics were performed on 3-km TT power output and mean values displayed in 
Figure 2. For reference, EX2 finishing times were as follows: FULL/PLA, 301.1 ± 32.2 
sec; SR/PLA, 300.7 ± 33.2 sec; FULL/CAF, 296.9 ± 37.8 sec; SR/CAF, 294.8 ± 39 sec. 
Statistics were performed on EX2 power output, but for reference, finishing times were as 
follows: Time trial performance had a clear order effect such that they rode progressively 
slower chronologically. Therefore, EX1 3-km TT performances were aggregated and are 
only used as a reference point in comparison to EX2 performances in the four experimental 
conditions. Average time trial power output for EX1 was 273.7 ± 69.2 W (mean finishing 
time: 294.9 ± 32.8 sec). For all conditions except SR/CAF, average power output and 
finishing time were lower the following morning for EX2. All comparisons presented 
henceforth are from the EX2 (morning) trials. Power output was ‘possibly’ greater (0.9 ± 
3.6%) following SR/PLA compared to FULL/PLA. Power output was ‘likely’ higher (5.5 
± 4.8%) following SR/CAF compared with SR/PLA. There were ‘unclear’ (1.9 ± 3.2%) 
differences in power output following SR/CAF compared to FULL/CAF. Power output 
was ‘very likely’ greater (6.5 ± 5.2%) following SR/CAF compared to FULL/PLA.  
Muscle Function 
Peak isokinetic torque, total work, and fatigue index data at 120 deg∙sec-1 are 
displayed in Table 3. There were no differences in peak torque between any of the 






There was a ‘likely trivial’ difference in total work (˗2.0 ± 6.4%) between SR/PLA 
and FULL/PLA. However, total work was ‘possibly’ higher (4.9 ± 7%) following SR/CAF 
compared to SR/PLA. Finally, there was a ‘likely trivial’ difference (3.5 ± 3.6%) between 
FULL/CAF and SR/CAF. 
Fatigue Index 
There were no differences in fatigue index when comparing FULL/PLA to 
SR/CAF, SR/PLA to SR/CAF, and FULL/CAF to SR/CAF. However, fatigue index was 
‘very likely’ higher (18.1 ± 11.5%) following FULL/PLA compared to SR/PLA. 
Muscle Soreness 
 Sleep condition did not seem to affect muscle soreness in the placebo or caffeine 
treatments. Additionally, treatment did not seem to affect muscles soreness following a 
night of sleep restriction. Muscle soreness was only different when comparing SR/CAF to 
FULL/PLA. Surprisingly, muscle soreness was ‘most likely’ lower (-42.7 ± 14.4%) 
following SR/CAF (20.8 ± 10.9mm) compared to FULL/PLA (34.7 ± 15mm).  
Responses to Fixed-Load Exercise 
HR and RPE 
 There were no differences in fixed-load HR between FULL/PLA and SR/PLA or 
between SR/CAF and SR/PLA. Fixed-load HR was ‘possibly’ higher (2.4 ± 3.4%) 
following SR/CAF compared to FULL/CAF. 
 There was no difference in RPE when comparing SR/PLA to FULL/PLA. RPE was 





RPE was ‘very likely’ lower following SR/CAF compared to FULL/PLA. Sleep condition 
had a ‘very likely’ effect on RPE with the caffeine treatment. Interestingly, RPE was ‘very 
likely’ lower (-7.4 ± 4.8%) following SR/CAF compared to FULL/CAF.  
VO2, VE, and RER 
 Sleep condition had an ‘unclear’ effect on VO2 during the placebo treatment (1.4 ± 
4.9%). VO2 was ‘likely’ lower (-5.3 ± 5.2%) following FULL/PLA compared to SR/CAF. 
There was a ‘possible’ effect of treatment (3.8 ± 6%) on morning performance. VO2 was 
‘possibly’ lower for SR/PLA compared to SR/CAF. Similarly, VO2 was ‘possibly’ lower 
(-2.0 ± 3.4%) following FULL/CAF compared to SR/CAF.   
 There were ‘unclear’ (0.3 ± 4.2%) differences between SR/PLA and FULL/PLA. 
Ventilation was ‘likely’ elevated (5.7 ± 5.2%) following SR/CAF compared to SR/PLA. 
Also, ventilation was ‘possibly’ elevated (1.5 ± 3.3%) SR/CAF (77 ± 8.9 L/min) compared 
to FULL/CAF.  
 There were ‘unclear’ differences in RER for all comparisons except when 
comparing FULL/PLA to SR/CAF (1.1 ± 1.6%). RER was ‘possibly’ lower for the 
FULL/PLA than for SR/CAF. 
Profile of Mood States 
Total Mood Disturbance 
Data for POMS total mood disturbance are displayed in Table 3. Total mood 
disturbance was ‘likely’ higher (7.1 ± 5.5%) following SR/PLA compared to FULL/PLA. 





to SR/PLA and ‘very likely’ lower (-7.5 ± 3.9%) following FULL/CAF as compared to 
SR/CAF. 
Fatigue-Inertia 
Fatigue-inertia was ‘very likely’ (11 ± 7.4%; 92% likelihood) greater following 
SR/PLA compared to FULL/PLA. Fatigue-inertia was ‘very likely’ greater (8.3 ± 5.5%) 
following SR/PLA compared to SR/CAF. Additionally, fatigue-inertia was ‘likely’ greater 
(6.2 ± 8%) following SR/CAF compared to FULL/CAF.  
Vigor-Activity 
Vigor-activity was ‘possibly’ lower (-7.3 ± 7.6%) in SR/PLA compared to 
FULL/PLA. Conversely, vigor-activity was ‘likely’ greater (18.3 ± 16.8%) following 
SR/CAF (47.4 ± 10.2) compared to SR/PLA. Additionally, vigor-activity was ‘possibly’ 






This study was designed to investigate the effect of sleep restriction on next 
morning cycling time trial performance following heavy exercise. Specifically, the goal of 
this study was to explore whether caffeine can compensate for the performance decrements 
following sleep restriction recently reported by our laboratory (13). Interestingly, there 
were no differences in performance between FULL/PLA compared to SR/PLA as 
previously suggested, but these findings may have been confounded by a nocebo effect 
(13, 47). Regardless, the most notable finding was that participants had ‘very likely’ 
increased power output (6.5%) following SR/CAF compared to FULL/PLA. While we 
anticipated that caffeine would attenuate performance decrements following sleep 
restriction, we did not expect to see performance exceeding that of a full night of sleep 
under any of the sleep restriction conditions. Although greater than expected, there was a 
‘likely’ improvement in power output (5.5%) following SR/CAF compared to SR/PLA. 
No systematic differences in muscle function were observed. This is consistent with our 
recent report that even with impaired recovery (as evidenced by 3-km time trial 
performance), there were no differences in muscle function (13). The majority of 
cardiorespiratory variables taken during the fixed-load phase prior to the time trial in the 
SR/CAF condition were altered. Specifically, ventilation, VO2, and HR were ‘possibly’ 
and ‘likely’ elevated. Altogether, these data suggest that caffeine supplementation can 
benefit performance through increasing power output following both sleep restriction and 





The effects of sleep restriction on recovery from exercise have been investigated in 
only a few studies. One observational study reported decreased sleep duration negatively 
impacted perceived recovery the following morning in elite soccer players that participated 
in night matches compared to day matches. While there were no specific performance 
measures, players reported lower perceived recovery following night matches and 
decreased sleep duration (21). Additional quantitative research supports the notion that 
sleep facilitates recovery. Previous findings showed a 4-5% decrease in cycling 
performance following heavy exercise and sleep restriction, presumably due to diminished 
muscle glycogen replenishment as well as reduced restoration of the immune and endocrine 
systems (13, 16, 47, 52). Despite such findings, the current study did not observe any 
difference in performance following heavy exercise and sleep restriction compared to a full 
night of sleep. Even with a full night of sleep it appears that the participants in this study 
had a difficult time recovering from the heavy exercise, whereas in our previous research 
and the study by Rae et al, the participants seemed to sufficiently recovery from previous 
exercise with a full night of sleep. What makes this finding even more surprising is that the 
negative psychological effects (mood disturbance, sleepiness, fatigue, etc.) of sleep 
restriction (49, 51), which have been used to explain impaired next-day performance, were 
present with SR compared to FULL. If the psychological alterations do contribute to 
performance impairment, they were not marked enough to influence performance in the 
current study. Due to the multifaceted nature of recovery, it is difficult to identify the reason 
for the inconsistent performance findings. One possible explanation for the current 





outcome (6). While our study was not designed to test the nocebo effect, it may be that 
subjects underperformed when they were confident that they were not receiving the 
caffeine treatment, as has been shown in previous literature. Six of our ten subjects were 
able to accurately identify when they received the placebo in the present study, which could 
be a reason they underperformed following placebo treatments. Furthermore, the 
participants in the current study certainly experienced the negative psychological effects 
of sleep restriction. It is well known that disrupted sleep causes disturbances in mood (49, 
51). Total mood disturbance following sleep restriction was 7.1% greater than a full night 
of sleep in the placebo condition. Furthermore, an 11% increase in fatigue was observed in 
the sleep restriction condition compared to the full night of sleep under placebo treatment.  
Despite the greater mood disturbance following sleep restriction, it was not enough to 
impact performance compared to FULL/CAF.  
While the results in the FULL/PLA condition were surprising, the outcomes 
following caffeine supplementation were more consistent with our hypothesis. Following 
sleep restriction, when participants received caffeine treatment, they had 5.5% greater 
power output than when they received placebo. This was enough of an increase to maintain 
3-km TT performance from the previous evening. This increase in power output with 
caffeine following SR supports the well-established efficacy of caffeine as an ergogenic 
aid for short-duration cycling performance (22, 33, 34, 61) as well as Wingate performance 
following sleep deprivation (53). Previous research by Souissi et al. demonstrated that 
when Wingate performance was assessed 36 hours following SDEP, caffeine improved 





placebo treatment following sleep restriction, caffeine supplementation resulted in similar 
peak and mean power output compared to a full night of sleep without caffeine (53). Along 
with altering performance, caffeine also moderately influenced psychological measures. 
After ingesting caffeine, participants had a modest but ‘possible’ 2% reduction in total 
mood disturbance in the sleep restriction condition compared to placebo. Although smaller 
in magnitude, these findings are in line with the literature, which documents decreased 
mood following sleep restriction, and furthermore, improved mood following caffeine 
supplementation despite a poor night of sleep. In a study evaluating caffeine 
supplementation following sleep deprivation, there was a 33% decrease in fatigue and a 
55% increase in vigor as assessed by the POMS survey (53). Additionally, supplementation 
with 300 mg of caffeine decreased fatigue by 6% and increased vigor by 39% following 
72 hours of sleep deprivation in Navy Seal trainees (36). The noted improvements in mood 
following caffeine supplementation supports previous knowledge that caffeine exerts its 
ergogenic properties through influence on the central nervous system and ratings of 
perceived exertion (34). Altogether, these findings suggest that caffeine ingestion is a 
worthwhile strategy to compensate for probable impairments in performance following a 
night of SR. 
In addition to observed alterations in time trial performance and mood, 
cardiorespiratory variables during submaximal exercise (fixed-load phase) seemed to be 
affected by sleep condition and caffeine supplementation. This observation is contradictory 
to our previous study which lacked any sleep-related alterations in physiological responses 





Considering there were modest changes in these variables in the SR/PLA or FULL/CAF 
conditions, we cannot attribute these findings to sleep restriction or caffeine 
supplementation alone. Sleep restriction and caffeine supplementation have been 
separately implicated with increasing levels of catecholamine levels, which could have 
secondary influences on these cardiorespiratory variables (23, 42, 57). Although these 
changes were present, it is important to note that cardiorespiratory variables were assessed 
during submaximal exercise, whereas time trial performance was by nature, higher in 
intensity.  
Based on the current findings, there is uncertainty surrounding the effects of sleep 
restriction on recovery from heavy exercise. While some research suggests that sleep 
restriction impedes recovery compared to a full night of sleep, the present study did not. 
Regardless, there were performance decrements the following morning that were 
compensated for following supplementation with caffeine. This further strengthens the 
well-established role caffeine plays as an ergogenic aid. While there were mood 
disturbances following sleep restriction that were improved following caffeine 
supplementation, it is not likely that mood was the only factor contributing to decreased 
morning performance. Perhaps negative expectations, or a ‘nocebo’ effect, contributed to 
the poor time trial performance in the morning trials in the placebo treatment. These 
findings necessitate further research considering the conflicting results between recent 
work done in our lab and the current findings regarding the effects of sleep restriction on 
recovery from heavy exercise and next day performance. Specifically, more definitive 





performance. Finally, more research is warranted to determine the effects of time of day 
































60.7± 8.0 290 ± 47 174.6 ± 7.0 69.8 ± 7.6 
Data are expressed as means ± SD. Peak Watts represents power output at final complete 







Table 2. Sleep Data 
 Sleep Onset Time Wake-Up Time Sleep Duration (hrs) Efficiency (%) 
































Data are expressed as means with ranges displayed below. FULL, full night of sleep; SR, sleep restriction; CAF, caffeine 
treatment; PLA, placebo treatment. Regardless of treatment, participants fasted from caffeine at least 24 hours before beginning 
the evening exercise session. Sleep efficiency is a measure of sleep quality ([time in bed ˗ sleep latency ˗ time awake/time in 





Table 3. Peak Torque, Total Work, and Fatigue Index 
 Peak Torque  
120 deg∙sec-1 (Nm) 
Total Work (J) Fatigue Index (%) 
FULL/PLA 164 ± 35 6020 ± 1548 31.0 ± 4.1b 
SR/PLA 163 ± 29 5920 ± 1726 25.7 ± 5.0 
SR/CAF 164 ± 36 6105 ± 1351a 29.6 ± 6.4 
FULL/CAF 166 ± 26 6366 ± 1552 32.9 ± 6.4 
Data are expressed as means ± SD. To assess fatigue index, participants performed 30 isokinetic leg 
extensions on the Biodex at 120 deg∙sec-1. All values are representative of morning exercise sessions; a, 








Table 4. Profile of Mood States (POMS) 
 Total Mood Disturbance Fatigue-Inertia Vigor-Activity 
FULL/PLA 41 ± 5a,b 42 ± 5.2 43.4 ± 10.1 
SR/PLA 44 ± 6c 46.9 ± 8e,f 40.1 ± 9.1h 
SR/CAF 43 ± 6 42.8 ± 5.6g 47.4 ± 10.2i,j 
FULL/CAF 40 ± 5d 40.3 ± 5.2 49.5 ± 10.3  
Data are expressed as means ± SD. Total mood disturbance was assessed using the POMS questionnaire, which 
investigates transient mood states; a, ‘likely’ lower than SR/PLA [95% LH]; b, ‘likely’ lower [83% LH] than SR/CAF; 
c ‘possibly’ greater [53% LH] than SR/CAF; d ‘very likely’ lower [98% LH] than SR/CAF;  e, ‘very likely’ greater 
[92% LH] than FULL/PLA; f, ‘very likely’ greater [95% LH] than SR/CAF; g,  ‘likely’ greater [79% LH] than 
FULL/CAF; h, ‘possibly’ lower [72% LH] than FULL/PLA; i, ‘likely’ greater [93% LH] compared to SR/PLA; j, 





Table 5. Responses to Fixed-Load Exercise 
 Steady State HR 
(bpm) 
RPE VO2 (mL/kg/min) Ventilation 
(L/min) 
RER 
FULL/PLA 153 ± 14a 12.5 ± 1.3f 40.9 ± 3.1b 72.5 ± 7.2d 0.86 ± 0.04e 
SR/PLA 155 ± 19 12.7 ± 1.6f 41.6 ± 4.9c 73.0 ± 9.7d 0.87 ± 0.04 
SR/CAF 156 ± 15 11.8 ± 1.1 43.1 ± 4.1 77.0 ±8.9 0.87 ± 0.05 
FULL/CAF 152 ± 15a 12.6 ± 1.3f 42.1 ± 2.5c 75.9 ± 9.2e 0.85 ± 0.03 
Data are expressed as means ± SD. a, ‘possibly’ lower than SR/CAF [FULL/CAF, 55% LH; FULL/PLA, 58% LH]; b, ‘likely’ 
lower than SR/CAF [86% LH]; c, ‘possibly’ lower than SR/CAF [SR/PLA, 70% LH; FULL/CAF, 50% LH];   
d, ‘likely’ lower than SR/CAF [FULL/PLA, 94% LH; SR/PLA, 88% LH]; e, ‘possibly’ lower than SR/CAF [ventilation, 63% 

































Figure 1. Experimental design and primary dependent measures. Sleep+, full night of sleep; Sleep-, night of sleep 












Figure 2. 3-km Time Trial Performance Power Output 
 
Figure 2. Mean power output in the morning following condition and treatment. SR/PLA, 
sleep restriction and placebo; SR/CAF, sleep restriction and caffeine; FULL/CAF, full 
night of sleep and caffeine; FULL/PLA, full night of sleep and placebo. The dashed 
horizontal line represents the average power output for the 3-km time trial in EX1, which 
was 273.7 ± 69.2 W; a, ‘possibly’ greater than FULL/PLA (0.9 ± 3.6%; 44% LH); b, 
‘likely’ greater than SR/PLA (5.5 ± 4.8%; 94%); c, ‘very likely’ higher than FULL/PLA 
































1.  Abedelmalek S, Chtourou H, Aloui A, Aouichaoui C, Souissi N, Tabka Z. Effect of 
time of day and partial sleep deprivation on plasma concentrations of IL-6 during a 
short-term maximal performance. Eur J Appl Physiol 2013;113(1):241–8.  
2.  Armstrong LE, VanHeest JL. The Unknown Mechanism of the Overtraining 
Syndrome. Sport Med 2002;32(3):185–209. 
3.  Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: Unraveling 
the mechanisms of the nocebo effect. Neuroscience 2007;147(2):260–71. 
4.  Besedovsky L, Lange T, Born J. Sleep and immune function. Pflügers Arch - Eur J 
Physiol 2012;463(1):121–37. 
5.  Buysse D, Reynolds C, Monk T, Berman S, Kupfer D. The Pittsburgh Sleep Quality 
Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry 
Res 1989;28(2):193–213. 
6.  Chase JD, Roberson PA, Saunders MJ, Hargens TA, Womack CJ, Luden ND. One 
night of sleep restriction following heavy exercise impairs 3-km cycling time-trial 
performance in the morning. Appl Physiol Nutr Metab 2017; 1-7.  
7.  Driver HS, Taylor SR. Exercise and sleep. Sleep Med Rev 2000;4(4):387–402. 
8.  Edwards B. Altered sleep–wake cycles and physical performance in athletes. 
Physiol Behav 2007;90(2):274–84. 
9.  Erlacher D, Ehrlenspiel F, Adegbesan OA, Galal El-Din H. Sleep habits in German 
athletes before important competitions or games. J Sports Sci 2011;29(8):859–66. 
10.  Ferrara M, De Gennaro L. How much sleep do we need? Sleep Med Rev 
2001;5(2):155–79. 
11.  Frank MG. The Mystery of Sleep Function: Current Perspectives and Future 
Directions. Rev Neurosci 2006;17(4):375–92. 
12.  Frank MG, Benington JH. The role of sleep in memory consolidation and brain 
plasticity: dream or reality? Neuroscientist 2006;12(6):477–88. 
13.  Fullagar HHK, Skorski S, Duffield R, Julian R, Bartlett J, Meyer T. Impaired sleep 
and recovery after night matches in elite football players. J Sports Sci 
2016;34(14):1333–9. 
14.  Graham TE, Rush JWE, Soeren MH van. Caffeine and Exercise: Metabolism and 
Performance. Can J Appl Physiol 1994;19(2):111–38. 
15.  Graham TE, Spriet LL. Metabolic, catecholamine, and exercise performance 







16.  HajSalem M, Chtourou H, Aloui A, Hammouda O, Souissi N. Effects of partial sleep 
deprivation at the end of the night on anaerobic performances in judokas. Biol 
Rhythm Res 2013;44(5):815–21. 
17.  Halson SL. Nutrition, sleep and recovery. Eur J Sport Sci 2008;8(2):119–26. 
18.  Hausswirth C, Louis J, Aubry A, Bonnet G, Duffield R, Le Meur Y. Evidence of 
disturbed sleep and increased illness in overreached endurance athletes. Med Sci 
Sports Exerc 2014;46(5):1036–45. 
19.  Hopkins WG. A spreadsheet for deriving a confidence interval, mechanistic 
inference, and clinical inference from a p-value. Sportscience 2007;11:16–9. 
20.  Hopkins WG. How to Interpret Changes in an Athletic Performance Test [Internet]. 
Sportscience 2004;8:1–7.  
21.  Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive Statistics for 
Studies in Sports Medicine and Exercise Science. Med  Sci  Sport Exerc 
2009;41(1):3–12. 
22.  Ivy JL, Costill DL, Fink WJ, Lower RW. Influence of caffeine and carbohydrate 
feedings on endurance performance. [Internet]. Med Sci Sports 1979;11(1):6–11.  
23.  Keisler BD, Armsey TD. Caffeine As an Ergogenic Aid. Curr Sports Med Rep 
2006;5(4):215–9. 
24.  Lieberman H, Tharion W, Shukitt-Hale B, Speckman K, Tulley R. Effects of 
caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy 
SEAL training. Psychopharmacology (Berl) 2002;164(3):250–61. 
25.  Martin BJ. Effect of sleep deprivation on tolerance of prolonged exercise. Eur J Appl 
Physiol Occup Physiol 1981;47(4):345–54. 
26.  Mejri MA, Yousfi N, Mhenni T, et al. Does one night of partial sleep deprivation 
affect the evening performance during intermittent exercise in Taekwondo players? 
J Exerc Rehabil 2016;12(1):47–53. 
27.  Mougin F, Bourdin H, Simon-Rigaud ML, Didier JM, Toubin G, Kantelip JP. 
Effects of a selective sleep deprivation on subsequent anaerobic performance. Int J 
Sports Med 1996;17(2):115–9. 
28.  Mougin F, Simon-Rigaud ML, Davenne D, et al. Effects of sleep disturbances on 
subsequent physical performance. Eur J Appl Physiol Occup Physiol 
1991;63(2):77–82. 
29.  Oliver SJ, Costa RJS, Walsh NP, Laing SJ, Bilzon JLJ. One night of sleep 








30.  Omiya K, Akashi YJ, Yoneyama K, Osada N, Tanabe K, Miyake F. Heart-Rate 
Response to Sympathetic Nervous Stimulation, Exercise, and Magnesium 
Concentration in Various Sleep Conditions. Int J Sport Nutr Exerc Metab 
2009;19:127–35. 
31.  Opstad PK, Aakvaag A, Rognum TO. Altered hormonal response to short-term 
bicycle exercise in young men after prolonged physical strain, caloric deficit, and 
sleep deprivation. Eur J Appl Physiol Occup Physiol 1980;45(1):51–62. 
32.  Rae DE, Chin T, Dikgomo K, et al. One night of partial sleep deprivation impairs 
recovery from a single exercise training session. Eur J Appl Physiol 
2017;117(4):699–712. 
33.  Reilly T, Deykin T. Effects of partial sleep loss on subjective states, psychomotor 
and physical performance tests. J Hum Mov Stud 1983;9:157–70. 
34.  Reilly T, Piercy M. The effect of partial sleep deprivation on weight-lifting 
performance. Ergonomics 1994;37(1):107–15.  
35.  Scott JPR, McNaughton LR, Polman RCJ. Effects of sleep deprivation and exercise 
on cognitive, motor performance and mood. Physiol Behav 2006;87(2):396–408. 
36.  Skein M, Duffield R, Edge J, Short MJ, Mundel T. Intermittent-Sprint Performance 
and Muscle Glycogen after 30h of Sleep Deprivation. Med Sci Sport Exerc 
2011;43(7): 1301-11. 
37.  Souissi M, Chtourou H, Abedelmalek S, Ghozlane I Ben, Sahnoun Z. The effects of 
caffeine ingestion on the reaction time and short-term maximal performance after 
36h of sleep deprivation. Physiol Behav 2014;131:1–6. 
38.  Souissi N, Sesboüé B, Gauthier A, Larue J, Davenne D. Effects of one night’s sleep 
deprivation on anaerobic performance the following day. [Internet]. Eur J Appl 
Physiol 2003;89(3–4):359–66.  
39.  Symons JD, VanHelder T, Myles WS. Physical performance and physiological 
responses following 60 hours of sleep deprivation. [Internet]. Med Sci Sports Exerc 
1988;20(4):374–80.  
40.  Thomas M, Sing H, Belenky G, et al. Neural basis of alertness and cognitive 
performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation 
on waking human regional brain activity. J Sleep Res 2000;9(4):335–52. 
41.  Webb WB, Agnew HW. Are we chronically sleep deprived? Bull Psychon Soc 
1975;6(1):47–8. 
42.  Wiles JD, Coleman D, Tegerdine M, Swaine IL. The effects of caffeine ingestion 
on performance time, speed and power during a laboratory-based 1 km cycling time-
trial. J Sports Sci 2006;24(11):1165–71. 
43.  Wilkinson RT, Edwards RS, Haines E. Performance following a night of reduced 






James Madison University 
Department of Kinesiology 
Consent for Investigative Procedure 
 
I, ______________________, hereby agree on _____________ (date) to participate in the 
research project conducted by Nicholas D. Luden, Ph.D. and Erin Horil from James 
Madison University titled Performance Impairment Following Sleep Restriction - Is 
Caffeine the Antidote? 
The purpose of this study is to determine the effects caffeine has on performance following 
recovery from exercise following sleep restriction. Additionally, this study aims to 
determine the effects that caffeine has on performance following heavy exercise, compared 
to a full night of rest without caffeine. 
Subject Responsibility 
I understand that I will undergo the following testing: 
This study consists of 11 separate visits performed, 10 of which will involve exercise on a 
resistance exercise device and 10 of which will involve exercise on a stationary bike 
(cardiovascular fitness test, two familiarization trials, and six exercise trials). All testing 
will occur in Godwin Hall, room 209, on the campus of James Madison University. You 
will also be asked about lifestyle behaviors such as smoking and physical activity and 
complete dietary and physical activity records. The total time commitment is estimated to 
be less than 16 hours over the course of 6 weeks. 
Preliminary Trial (1 visit; 60 min):  
After completing this consent form and the health history screening, if you meet the 
inclusion criteria for the study, researchers will measure your height and body weight. 
You will then be asked to perform a maximal cardiovascular fitness test to determine your 
maximum oxygen consumption (VO2max). You will be asked to ride a stationary bike at an 
initial workload that is ‘fairly easy’. The workload will then be increased every two minutes 
until fatigue is reached, determined by either: 1) your request to stop due to fatigue, or 2) 
inability to maintain a cadence of ≥50 revolutions per minute. You will be verbally 
encouraged to continue to obtain an accurate measurement of VO2max. To access oxygen 
consumption, you will need to breathe through a mouthpiece/breathing apparatus which 





Familiarization Phase (2 visits; total time of 180 min):   
The familiarization phase will consist of two consecutive days of exercise trials. Procedures 
will be the same as the experimental trials detailed below. However, no blood samples will 
be obtained and you will not be assigned to sleep and caffeine conditions. 
Experimental Phase 
Exercise Trial 1 (4, 120 min each) 
You will be asked to arrive at the human performance lab between 3-5pm, not having 
consumed alcohol, tobacco or caffeine 24 hrs prior to testing.  
Muscle Soreness – Upon arriving to the lab, you will be asked to rate your level of muscle 
soreness using a scale ranging from 0-100 (taken walking up stairs, walking down stairs 
and standing) and subjective ratings of energy and fatigue will be assessed using a short 
questionnaire. 
3-km Cycling Time Trial – Immediately following the questionnaires, you will be prompted 
to perform a 20-min warm-up on a stationary cycle ergometer. During the warm-up, several 
measurements will be taken (detailed below). Following the warm-up, you will be 
prompted to transition into a 3-km computer-simulated time trial on the cycle ergometer. 
This will last approximately 4-7 minutes and you will be reminded to treat this like a 
competition. 
Skeletal Muscle Function – 10 minutes following the 3-km cycling time trial, you will 
perform a muscle strength test where you will be asked to push as hard as possible against 
a shin pad for 30 consecutive leg extensions.   
60-minute Sprint Interval – Immediately following completion of the skeletal muscle 
function testing, you will complete 60 min of sprint intervals. You will only perform these 
intervals on Exercise Trial 1. You will be asked to cycle at high intensities for 2-minute 
intervals, separated by 2 min of moderate intensity cycling. Intensity will be progressively 
decreased throughout to permit you to finish the 60-minute session. 
Exercise Trial 2 (4, 60 min each) 
You will be asked to arrive at the human performance lab between 7-9 am, not having 
consumed alcohol, tobacco, or caffeine 24 hrs prior to testing.  
Muscle Soreness – Upon arriving to the lab, you will be asked to rate your level of muscle 
soreness using a scale ranging from 0-100 (taken while walking up stairs, walking down 
stairs, and standing) and subjective ratings of energy and fatigue will be assessed using a 






3-km Cycling Time Trial – You will then be asked perform a 20-min warm-up on a 
stationary cycle ergometer, then perform a 3-km computer-simulated time trial on the cycle 
ergometer. This will last approximately 4-7 minutes.  
Skeletal Muscle Function – 10 minutes following the 3-km cycling time trial, you will 
again perform 30 consecutive leg extensions on the resistance exercise device as described 
above.  
Measurements During 20-Minute Warm-Up 
Heart Rate & Rate of Perceived Exertion (HR & RPE) 
You will be fitted for a heart rate monitor so that we can measure your heart rate throughout 
the exercise trial. Additionally, you will be asked to rate your level of exertion on a scale 
from 6 to 20 at various points throughout your warm up. 
Glucose & Lactate (GLU & LAC) 
Finger-stick blood samples (1-2 drops of blood) will be obtained at min 10 and min 20 of 
the warm-up preceding the 3km time trial for measurement of blood sugar and lactic acid.  
Oxygen Consumption, Ventilation, & Respiratory Exchange Ratio (VO2, VE & 
RER) 
You will also be hooked up to a mouth-piece (and nose clip) in 2 x 5-minute increments 
during the warm-up for measurement of oxygen consumption and other measures of 
cardiorespiratory function. 
Sleep Protocol: 
Sleep will be measured, but not controlled, during the familiarization trials. During the 
experimental phases, you will be randomly assigned to a sleep and caffeine condition: a 
full night of sleep with placebo, a full night of sleep with caffeine, a night of sleep 
restriction with placebo, or a night of sleep restriction with caffeine. You will either be 
given a caffeine pill or placebo pill filled with rice flour, but you will not know which 
treatment you are receiving. You will not know your assigned sleep condition until 
completion of the first exercise trial. The sleep condition will be randomly selected for 
each exercise phase such that you may be assigned each sleep condition, or multiples of 
the same sleep/caffeine conditions. Following the first night of sleep assignment, you will 
be asked to record what you wore to sleep and replicate that on the second night of sleep 
assignment. You will also be asked to download a smartphone application, Sleep Cycle, 
which will detect movement during sleep, and wake up either 3.5 or 7.5 hrs following sleep 
onset, dependent upon sleep assignment for the night. Finally, you will wear an 
accelerometer to record movements while you sleep. Should you not comply with sleep 
protocols, you will be given another chance to complete the study seven days later. Failure 








Caffeine pills will be prepared for you individually. The caffeine treatment will consist of 
6mg caffeine powder per kilogram body weight. Placebo pills will be filled with rice 
flour. You will be prompted to consume the treatment pill one hour before your visit for 
EX 2. You will not know the treatment you are receiving at any time during the study. At 
the conclusion of the study, you will be asked to guess which treatment you received for 
each condition. 
Dietary and Exercise Controls: 
You will be asked to record all food and beverage intake for 24 hrs preceding the first 
exercise trial and the day of EX 2. After the initial exercise trial, you will be provided with 
copies of your dietary records and instructed to replicate their dietary habits for the second 
EX phase. You will be asked to report to all testing after a >2 hr fast. You will be asked to 
consume Ensure Active High Protein Shake within 1 hour of completing the first exercise 
trial. Additionally, you will be instructed to refrain from consuming anything other than 
water during the 2 hours following EX1. You will be asked to record of dietary intake 
following EX1, and replicate that seven days later after the second EX1 trial, and seven 
days after that for the third EX1 trial. For all conditions, you will be given a standardized 
breakfast to consume two hours before beginning EX2. You will also be instructed to 
record all physical activity 72 hrs prior to the first exercise trial in all phases and the day 
of EX 2. Additionally, you will be instructed to avoid physical activity between the first 
and second exercise trials, and to keep physical activity habits consistent between all 
exercise phases. 
Risks/Benefits: 
Skeletal Muscle Function 
The risks of muscle function testing include soreness from exertion 24-48 hours post and 
potential lightheadedness or loss of consciousness if correct form is not utilized.  You will 
be instructed in correct form and breathing techniques prior to testing. 
Sleep Disruption 
The consequences of a single night of sleep restriction comparable to this investigation 
have not been well documented but include impaired insulin sensitivity, increased 
sleepiness and fatigue, and reduced alertness and constant attentiveness. The latter have 
the potential to impact short-term academic performance, decision-making and tasks such 









According to the American College of Sports Medicine’s Guidelines for Exercise Testing 
and Prescription, the risk associated with heavy exercise for individuals categorized as 
“low risk” is very minimal, and physician supervision is not necessary.  The conditions that 
the exercise sessions are to take place are likely safer than the typical exercise environments 
of the subjects. If you do not meet ACSM criteria for “low risk”, you will not be allowed 
to participate in the study. In the unlikely event of cardiac or other complications during 
exercise, an emergency plan is in place. This includes immediate access to a phone to call 
emergency personnel. In addition, at least one of the listed investigators will be present 
during the exercise sessions, and all are CPR certified.   
Caffeine Ingestion 
The risks and side effects associated with caffeine supplementation include: rapid heart 
rate, elevated blood pressure, headache, nausea, vomiting, restlessness, agitation, and 
anxiety.  
Blood Sampling 
The risks of finger-stick blood sampling include possible mild bruising, and the risk of 
transfer of blood-borne pathogens, as well as possible risks of infection or skin irritation.  
These risks are considered to be minimal, and all safety precautions for handing blood 
samples will be followed according to OSHA protocols, including: investigators will wear 
latex gloves at all times during blood sampling and testing. A sharps container lined with 
a biohazard bag will be used for all sharp objects involved in the blood sampling; all other 
materials (i.e. gloves, gauze pads, etc.) used during the sampling will be put in a separate 
waste disposal unit lined with a biohazard bag. All investigators who will be involved in 
blood draws (and handling of blood) have been trained in these phlebotomy techniques, 
and completed JMU blood-borne pathogen training. A total of <10 milliliters of blood will 
be obtained throughout the course of the study, which is roughly 2% of the amount of blood 
typically obtained during blood donation (1 pint or 473 milliliters) 
Performance incentive: 
The top 5 3-km time trial performers will be entered into a drawing to win $150. Individuals 
with the top 6-10 times will be entered into a drawing to win $75. Times from both EX2 
trials will be averaged to determine the top performers. 
Confidentiality: 
The results of this research will be presented at conferences and published in exercise 
science journals.  The results of this project will be coded in such a way that your identity 
will not be attached to the final form of this study.  The researcher retains the right to use 
and publish non-identifiable data.  However, you can ask that your data be removed from 
the study at any point prior to presentation and publication.  While individual responses 
are confidential, aggregate data will be presented representing averages or generalizations 
about the responses as a whole.  All data will be stored in a secure location accessible only 





Participation & Withdrawal: 
Your participation is entirely voluntary.  You are free to choose not to participate.  Should 
you choose to participate, you can withdraw at any time without consequences of any kind.  
Your right to withdraw includes the right to request that your blood samples be discarded 
at any time. To dispose of your samples, your samples will be rinsed down a chemical drain 
in our laboratory or will be disposed of in a biohazard container. Again, your sample will 
not be identifiable without the coding document that will be locked away in a filing cabinet.  
Questions: 
You may have questions or concerns during the time of your participation in this study, or 
after its completion.  If you have any questions about the study, contact Nicholas D. Luden, 
Ph.D. at ludennd@jmu.edu or by phone at 540-568-4068. 
 
Giving of Consent: 
I have read this consent form and I understand what is being requested of me as a 
participant in this study.  I freely consent to participate.  I have been given satisfactory 
answers to my questions.  The investigator provided me with a copy of this form.  I certify 
that I am at least 18 years of age. 
 
   
Name of Participant  (Printed)  Name of Researcher(s)  (Printed) 
   
Name of Participant  (Signed)  Name of Researcher(s)  (Signed) 
   
  Date    Date 
 
For questions about your rights as a research subject, you may contact the chair of JMU’s 






AHA/ACSM Health/Fitness Facility Pre-participation Screening Questionnaire 
Assess your health status by marking all true statements 
______________________________________________________________________________________ 
History 
You have had: 
   a heart attack 
   heart surgery 
   cardiac catheterization 
   coronary angioplasty (PTCA)        
    pacemaker/implantable cardiac 
   defibrillator/rhythm disturbance 
   heart valve disease 
   heart failure 
   heart transplantation 
   congenital heart disease 
Symptoms 
   You experience chest discomfort with exertion 
   You experience unreasonable breathlessness 
   You experience dizziness, fainting, or blackouts 
   You take heart medications 
Other Health Issues 
   You have diabetes 
   You have asthma or other lung disease 
   You have burning or cramping sensation in your lower legs when walking short distances 
   You have musculoskeletal problems that limit your physical activity 
   You have concerns about the safety of exercise 
   You take prescription medication(s) 
______________________________________________________________________________ 
Cardiovascular risk factors 
   You are a man older than 45 years      
 You smoke, or quit smoking within the  
previous 6 months 
   Your blood pressure is > 140/90 mmHg 
   You do not know your blood pressure 
   You take blood pressure medication 
   Your blood cholesterol level is > 200 mg/dl 
   You do not know your cholesterol level 
   You have a close blood relative who 
had a heart attack or heart surgery before age  
55 (father or brother) or age 65 (mother or sister) 
   You are physically inactive (i.e. you get  
< 30 minutes of physical activity on at least 3 days of the week) 
   You are > 20 pounds overweight 
______________________________________________________________________________________ 
 
   None of the above 
If you marked any of these 
statements in this section, consult 
your physician or other appropriate 
health care provider before engaging 
in exercise.  You may need to use a 
facility with a medically qualified 
staff. 
If you marked two or more of the 
statements in this section, you should 
consult your physician or other 
appropriate health care provider 
before engaging in exercise.  You 
might benefit from using a facility 
with a professionally qualified 
exercise staff to guide your exercise 
program. 
You should be able to exercise safely 
without consulting your physician or 
other appropriate health care 
provider in a self-guided program or 
almost any facility that meets your 





The Pittsburgh Sleep Quality Index (PSQI) 
Instructions: The following questions relate to your usual sleep habits during the past month only. Your answers 
should indicate the  most accurate reply for the majority of days and nights in the past month. Please answer all 
questions. During the past month, 
1. When have you usually gone to bed? ______________ 
2. How long (in minutes) has it taken you to fall asleep each night? ______________ 
3. When have you usually gotten up in the morning? ______________ 
4. How many hours of actual sleep do you get at night? (This may be different than the number of hours you 
spend in bed) ______________ 
  5.  During the past month, how often have you   Not during  Less than  Once or  Three or  
had trouble sleeping because you…  the past  once a  twice a  more times  
  month (0)  week (1)  week (2)  week (3) 
  a. Cannot get to sleep within 30 minutes     
  b. Wake up in the middle of the night or early 
morning 
    
  c. Have to get up to use the bathroom     
  d. Cannot breathe comfortably     
  e. Cough or snore loudly     
  f. Feel too cold     
  g. Feel too hot     
  h. Have bad dreams     
  i. Have pain     
  j.  Other reason(s), please describe, 
including how often you  have had trouble 
sleeping because of this reason(s): 
    
  6.  During the past month, how often have you 
taken medicine  (prescribed or “over the 
counter”) to help you sleep? 
    
  7.  During the past month, how often have 
you had trouble staying  awake while driving, 
eating meals, or engaging in social activity? 
    
  8.  During the past month, how much of a 
problem has it been for  you to keep up 




    Very  Fairly  Fairly  Very  
    good (0)  good (1)  bad (2)  bad (3) 
  9.  During the past month, how would 
you rate your sleep  quality overall? 
    
   Component 1   #9 Score ....................................................................................................... C1_______ 
  Component 2    #2 Score (≤15min=0; 16-30 min=1; 31-60 min=2, >60 min=3) + #5a Score (if sum  
is equal 0=0; 1-2=1; 3-4=2; 5-6=3) .............................................................. C2_______ 
  Component 3   #4 Score (>7=0; 6-7=1; 5-6=2; <5=3) .......................................................... C3_______ 
  Component 4    (total # of hours asleep)/(total # of hours in bed) x 100  
>85%=0, 75%-84%=1, 65%-74%=2, <65%=3 ............................................. C4_______ 
  Component 5   Sum of Scores #5b to #5j (0=0; 1-9=1; 10-18=2; 19-27=3).......................... C5_______ 





  Component 7   #7 Score + #8 Score (0=0; 1-2=1; 3-4=2; 5-6=3)........................................... C7_______ 
  
      Add the seven component scores together ________ Global PSQI Score ________ 
 
Buysse, D.J., Reynolds III, C.F., Monk, T.H., Berman, S.R., & Kupfer, D.J. (1989). The Pittsburgh Sleep Quality Index: A new 
instrument for psychiatric  practice and research. Journal of Psychiatric Research, 28(2), 193-213. 
Reprinted with permission from copyright holder for educational purposes per the University of Pittsburgh, Sleep Medicine Institute, 






Daily Activity Records 
Subject #   Date:_____________ 
 
Date 







(use scale below) 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 





7 Very, very light 
8 
9 Very light 
10 
11 Fairly light 
12 




17 Very hard 
18 





















     
     
     
     
     
     
     
     
     
     
 
Adapted From:  Lee RD, Nieman DC. Nutritional Assessment. 2nd ed. United States of 










Height       Weight    _ 
 
Typical Exercise Habits over the Past 3-6 Months: 
 
Average number of days of cycling per week     
Average number of hours of cycling per week    
Briefly describe your cycling habits over the past 3-6 months: 
Average number of days of resistance exercise/weight lifting per week 
_____________ 
Average number of days of resistance exercise/weight lifting per week 
_____________ 
Briefly describe your resistance training habits over the past 3-6 months: 
 
Do you have a muscle or joint injury/condition that precludes the completion of the 
cycling or muscle function protocol? If yes, please explain. 
 
 
Are you allergic to wheat? 
 
Do you have gluten intolerance? 
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